Highlights

Healthcare mobility

The economic management of compensation between regions:  since 2010, the mobility of labile blood components has been included in the national healthcare mobility, therefore in Italy’s Transfusion Services Information System…

05 July, 2017

Plasma and plasma-derived medicines self sufficiency

Under current Italian legislation, the Italian National Blood Centre (CNS) is entrusted with the coordination and technical-scientific support for the production planning of plasma and plasma-derived medicinal products (PDMPs). In…

05 July, 2017

International relations

The Italian National Blood Centre (CNS) performs coordination and technical-scientific control activities in matters governed by Law no. 219 of 21st October 2005, “New regulations for transfusion activities and national…

05 July, 2017

© 2024 Centro Nazionale Sangue - Tutti i diritti riservati